BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 11560059)

  • 1. Protein models in drug discovery.
    Norin M; Sundström M
    Curr Opin Drug Discov Devel; 2001 May; 4(3):284-90. PubMed ID: 11560059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Importance of molecular computer modeling in anticancer drug development.
    Geromichalos GD
    J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From protein domains to drug candidates-natural products as guiding principles in the design and synthesis of compound libraries.
    Breinbauer R; Vetter IR; Waldmann H
    Angew Chem Int Ed Engl; 2002 Aug; 41(16):2879-90. PubMed ID: 12203413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural proteomics in drug discovery.
    Tari LW; Rosenberg M; Schryvers AB
    Expert Rev Proteomics; 2005 Aug; 2(4):511-9. PubMed ID: 16097885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicted role for the archease protein family based on structural and sequence analysis of TM1083 and MTH1598, two proteins structurally characterized through structural genomics efforts.
    Canaves JM
    Proteins; 2004 Jul; 56(1):19-27. PubMed ID: 15162483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computer-based design of novel protein structures.
    Butterfoss GL; Kuhlman B
    Annu Rev Biophys Biomol Struct; 2006; 35():49-65. PubMed ID: 16689627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct correlation between proteins' folding rates and their amino acid compositions: an ab initio folding rate prediction.
    Ma BG; Guo JX; Zhang HY
    Proteins; 2006 Nov; 65(2):362-72. PubMed ID: 16937389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PFRES: protein fold classification by using evolutionary information and predicted secondary structure.
    Chen K; Kurgan L
    Bioinformatics; 2007 Nov; 23(21):2843-50. PubMed ID: 17942446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of the druggable concavity in homology models using the PLB index.
    Soga S; Shirai H; Kobori M; Hirayama N
    J Chem Inf Model; 2007; 47(6):2287-92. PubMed ID: 17935312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein design with L- and D-alpha-amino acid structures as the alphabet.
    Durani S
    Acc Chem Res; 2008 Oct; 41(10):1301-8. PubMed ID: 18642934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein structure similarity clustering (PSSC) and natural product structure as inspiration sources for drug development and chemical genomics.
    Dekker FJ; Koch MA; Waldmann H
    Curr Opin Chem Biol; 2005 Jun; 9(3):232-9. PubMed ID: 15939324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug design strategies for targeting G-protein-coupled receptors.
    Klabunde T; Hessler G
    Chembiochem; 2002 Oct; 3(10):928-44. PubMed ID: 12362358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural genomics and drug discovery: all in the family.
    Weigelt J; McBroom-Cerajewski LD; Schapira M; Zhao Y; Arrowsmith CH
    Curr Opin Chem Biol; 2008 Feb; 12(1):32-9. PubMed ID: 18282486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Doing more than just the structure-structural genomics in kinase drug discovery.
    Marsden BD; Knapp S
    Curr Opin Chem Biol; 2008 Feb; 12(1):40-5. PubMed ID: 18267130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-throughput protein crystallography and drug discovery.
    Tickle I; Sharff A; Vinkovic M; Yon J; Jhoti H
    Chem Soc Rev; 2004 Oct; 33(8):558-65. PubMed ID: 15480479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homology-based modelling of targets for rational drug design.
    Wieman H; Tøndel K; Anderssen E; Drabløs F
    Mini Rev Med Chem; 2004 Sep; 4(7):793-804. PubMed ID: 15379646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular modelling of drug targets: the past, the present and the future.
    Dahl SG; Sylte I
    Basic Clin Pharmacol Toxicol; 2005 Mar; 96(3):151-5. PubMed ID: 15733208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Network scaling invariants help to elucidate basic topological principles of proteins.
    Krishnan A; Giuliani A; Zbilut JP; Tomita M
    J Proteome Res; 2007 Oct; 6(10):3924-34. PubMed ID: 17850063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential implications of availability of short amino acid sequences in proteins: an old and new approach to protein decoding and design.
    Otaki JM; Gotoh T; Yamamoto H
    Biotechnol Annu Rev; 2008; 14():109-41. PubMed ID: 18606361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.